Login
Search result (1-20 of 50)Download
|
Symbol
|
XLOLTQ | RMA1UV | NIZRCH | RMBUPV | RMAG9V | RMAQXV | NQLRCH | NTSRCH | RMBWZV | RMAMHV | ZIKLTQ | OACRCH | RMAK4V | ODNRCH | KTAXDU | ZTLLTQ | ZWDLTQ | RMAWMV | MBPQJB | KXASDU |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible with European Knock-In | Worst of Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Auto-Callable Multi Defender VONTI | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Lock-In Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Underlying
|
Bayer AG / Novo Nordisk AS (B) / Sanofi S.A. | LVMH Moet Hennessy Louis Vuitton / Nestlé S.A. / Novo Nordisk AS (B) | Bayer AG / Novartis AG / Novo Nordisk AS (B) / Roche AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG | Lindt & Sprüngli AG PS / Novo Nordisk AS (B) / Roche AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) | Novartis AG / Novo Nordisk AS (B) / Sandoz Group AG | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Pfizer Inc. | Eli Lilly & Co. / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG | Eli Lilly & Co. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Moderna Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
21.01.2025 | 07.04.2025 | 04.06.2025 | 17.06.2025 | 22.12.2025 | 27.01.2025 | 05.08.2025 | 26.11.2025 | 16.03.2026 | 02.03.2026 | 15.09.2025 | 08.10.2025 | 05.08.2025 | 03.11.2025 | 24.10.2025 | 10.11.2025 | 24.11.2025 | 02.12.2025 | 28.05.2025 | 17.11.2025 |
| Bid | 40.930 | 95.30 | 80.52 | 100.80 | 100.80 | 99.00 | 98.42 | 98.27 | 91.50 | 94.80 | 89.21 | 92.19 | 97.40 | 90.75 | 90.80 | 94.06 | 90.31 | 92.90 | 36.650 | 87.70 |
| Ask | - | 96.10 | 81.32 | 101.80 | 101.70 | 99.80 | 99.22 | 99.07 | 92.50 | 95.60 | 90.01 | 92.99 | 98.20 | 91.55 | 91.80 | 94.86 | 91.11 | 93.70 | - | 88.70 |
Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.
Your Bookmarks (0)